Table 2.
Name | Applications | Ref. |
---|---|---|
Liposomal Amikacin |
Mycobacterium avium complex lung disease | [97] |
Liposomal Clarithromycin |
Clinical isolates of P. aeruginosa from the lungs of cystic fibrosis patients | [98] |
Liposomal polymyxin B |
Higher drug penetration into pulmonary epithelial lining fluid, which resulted in superior efficacy | [99] |
Liposomal amphotericin B |
An excellent candidate for the first-line treatment of patients with suspected fungal infection, based on prolonged neutropenic fever not responding to antibacterial therapy | [100] |
Liposomal Mupirocin |
Therapeutic potential for infections involving MDR bacteria | [101] |
Liposomal Vancomycin |
Applied directly on MRSA-infected skin wounds in mice | [102] |
Liposomal Daptomycin and Clarithromycin |
Treatment of MRSA infection | [103] |